Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Fixed Capital/Sales(x) 0.450.450.440.470.44

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.45 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.45
Mar20230.45
Mar20220.44
Mar20170.47
Mar20160.44

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44
-6.38
Mar2017 0.47
6.82
Mar2016 0.44 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,951.4 Cr -4.8% 34.2% 76.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4.8%

34.2%

76.8%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses